Cargando…

SET7/9 promotes hepatocellular carcinoma progression through regulation of E2F1

Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies worldwide. Histone-lysine N-methyltransferase SET7/9 is a protein lysine monomethylase that methylates histone H3K4 as well as various non-histone proteins. Deregulation of SET7/9 is frequently detected in human cancers. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Ye, Wang, Xinling, Liu, Hong, Li, Guimei, Yu, Weiping, Ma, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111541/ https://www.ncbi.nlm.nih.gov/pubmed/30106440 http://dx.doi.org/10.3892/or.2018.6621

Ejemplares similares

Opposite Effects of SET7/9 on Apoptosis of Human Acute Myeloid Leukemia Cells and Lung Cancer Cells
por: Gu, Ye, et al.
Publicado: (2017)

METTL9-SLC7A11 axis promotes hepatocellular carcinoma progression through ferroptosis inhibition
por: Bi, Fangfang, et al.
Publicado: (2023)

Oncogene or Tumor Suppressor: The Coordinative Role of Lysine Methyltransferase SET7/9 in Cancer Development and the Related Mechanisms
por: Gu, Ye, et al.
Publicado: (2022)

LINC00265 Promotes Metastasis and Progression of Hepatocellular Carcinoma by Interacting with E2F1 at The Promoter of CDK2
por: Ge, Beihai, et al.
Publicado: (2022)

E2F4 Promotes the Proliferation of Hepatocellular Carcinoma Cells through Upregulation of CDCA3
por: Liu, Junye, et al.
Publicado: (2021)

HOXB9 promotes endometrial cancer progression by targeting E2F3
por: Wan, Junhu, et al.
Publicado: (2018)

EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis
por: Chen, Shaofei, et al.
Publicado: (2018)

SAPCD2 promotes neuroblastoma progression by altering the subcellular distribution of E2F7
por: Zhang, Zi-Mu, et al.
Publicado: (2022)

Knockdown of CENPW Inhibits Hepatocellular Carcinoma Progression by Inactivating E2F Signaling
por: Zhou, Yajing, et al.
Publicado: (2021)

E2F1 mediated DDX11 transcriptional activation promotes hepatocellular carcinoma progression through PI3K/AKT/mTOR pathway
por: Yu, Yan, et al.
Publicado: (2020)

FGFR3(△7–9) promotes tumor progression via the phosphorylation and destabilization of ten-eleven translocation-2 in human hepatocellular carcinoma
por: Jin, Zhijian, et al.
Publicado: (2020)

microRNA-19a-3p and microRNA-376c-3p Promote Hepatocellular Carcinoma Progression Through SOX6-Mediated Wnt/β-Catenin Signaling Pathway
por: Cao, Xinling, et al.
Publicado: (2021)

Methylation of the epigenetic JMJD2D protein by SET7/9 promotes prostate tumorigenesis
por: Gu, Ruicai, et al.
Publicado: (2023)

CircLATS2 Regulates miR-520a-3p/E2F7/p-VEGFR2 Signaling Pathway to Promote Hepatocellular Carcinoma Progression and Angiogenesis
por: Wu, Yefeng, et al.
Publicado: (2022)

ISL-1 promotes pancreatic islet cell proliferation by forming an ISL-1/Set7/9/PDX-1 complex
por: Yang, Zhe, et al.
Publicado: (2015)

TDO Promotes Hepatocellular Carcinoma Progression
por: Li, Shanbao, et al.
Publicado: (2020)

TXNDC9 promotes hepatocellular carcinoma progression by positive regulation of MYC-mediated transcriptional network
por: Chen, Dawei, et al.
Publicado: (2018)

Factor VII promotes hepatocellular carcinoma progression through ERK-TSC signaling
por: Tsai, M-C, et al.
Publicado: (2015)

Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation
por: Chen, Peng, et al.
Publicado: (2020)

TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma
por: Xu, Fengkai, et al.
Publicado: (2019)

TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway
por: Ye, Yanqing, et al.
Publicado: (2023)

HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition
por: Huan, Hong-bo, et al.
Publicado: (2017)

KLHL7 promotes hepatocellular carcinoma progression and molecular therapy resistance by degrading RASA2
por: Chen, Lin, et al.
Publicado: (2023)

MIRLET7BHG promotes hepatocellular carcinoma progression by activating hepatic stellate cells through exosomal SMO to trigger Hedgehog pathway
por: Xia, Yunhong, et al.
Publicado: (2021)

ARHGAP9 suppresses the migration and invasion of hepatocellular carcinoma cells through up-regulating FOXJ2/E-cadherin
por: Zhang, Hong, et al.
Publicado: (2018)

HBV core promoter mutations and AKT upregulate S-phase kinase-associated protein 2 to promote postoperative hepatocellular carcinoma progression
por: Chen, Lubiao, et al.
Publicado: (2016)

MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation
por: Hong, Yinghui, et al.
Publicado: (2021)

Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma
por: Seitz, Tatjana, et al.
Publicado: (2020)

The histone methyltransferase Set7/9 promotes myoblast differentiation and myofibril assembly
por: Tao, Yazhong, et al.
Publicado: (2011)

Thymidine phosphorylase promotes malignant progression in hepatocellular carcinoma through pentose Warburg effect
por: Zhang, Qiang, et al.
Publicado: (2019)

DEAD-box Helicase 27 Promotes Hepatocellular Carcinoma Progression Through ERK Signaling
por: Xiaoqian, Wang, et al.
Publicado: (2021)

CircASPH Promotes Hepatocellular Carcinoma Progression Through Methylation and Expression of HAO2
por: Zhuo, Han, et al.
Publicado: (2022)

Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion
por: Zhang, Deguo, et al.
Publicado: (2023)

Resveratrol induces p53 in colorectal cancer through SET7/9
por: Liu, Zhonglun, et al.
Publicado: (2019)

Histone Methyltransferase G9a-Promoted Progression of Hepatocellular Carcinoma Is Targeted by Liver-Specific Hsa-miR-122
por: Yuan, Lan-Ting, et al.
Publicado: (2021)

MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma
por: Qu, Kai, et al.
Publicado: (2017)

A positive feedback loop of CENPU/E2F6/E2F1 facilitates proliferation and metastasis via ubiquitination of E2F6 in hepatocellular carcinoma
por: Liu, Yingyi, et al.
Publicado: (2022)

Protein Tyrosine Kinase 7 (PTK7) Promotes Metastasis in Hepatocellular Carcinoma via SOX9 Regulation and TGF-β Signaling
por: Wong, Tsz Lam Matthew, et al.
Publicado: (2022)

F-box protein FBXO22 mediates polyubiquitination and degradation of KLF4 to promote hepatocellular carcinoma progression
por: Tian, Xin, et al.
Publicado: (2015)

MiR-424-5p regulates cell cycle and inhibits proliferation of hepatocellular carcinoma cells by targeting E2F7
por: Zhao, Yichao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6leag3ku3djm73s8r1u1iilk0p